Borderline personality disorder: Toward integration

CNS Spectrums

Volumn 14, Issue 7, 2009, Pages 352-356

  Stein, Dan J ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BORDERLINE STATE; CASE REPORT; COGNITIVE DEFECT; ENVIRONMENT; FEMALE; GENETICS; HUMAN; METHODOLOGY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OBJECT RELATION; PATHOLOGY; PSYCHOANALYTIC THEORY; PSYCHOLOGICAL ASPECT;

BORDERLINE PERSONALITY DISORDER; COGNITION DISORDERS; ENVIRONMENT; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROPSYCHOLOGICAL TESTS; OBJECT ATTACHMENT; PSYCHOANALYTIC THEORY; YOUNG ADULT;

EID: 70350441885     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900022999     Document Type: Article

References (86)

1. Gunderson JG. Borderline personality disorder: ontogeny of a diagnosis. Am J Psychiatry. 2009;166:530-539.
2. Siever LJ, Davis KL. A psychobiological perspective on the personality disorders. Am J Psychiatry. 1991;148:1647-1658.
3. Melges FT, Swartz MS. Oscillations of attachment in borderline personality disorder. Am J Psychiatry. 1989;146:1115-1120. (Pubitemid 19229010)
4. Levy KN. The implications of attachment theory and research for understanding borderline personality disorder. Dev Psychopathol. 2005;17:959-986. (Pubitemid 43362199)
5. Giovanni L, Mauricio C, Benedetto F. Attachment theory and multiple integrated treatments of borderline patients. J Am Acad of Psychoanal Dyn Psychiatry. 2008;36:295-315.
6. Gabbard GO, Horowitz MJ. Insight, transference interpretation, and therapeutic change in the dynamic psychotherapy of borderline personality disorder. Am J Psychiatry. 2009;166:517-521.
7. Peter F, Anthony B. The Development of Borderline Personality Disorder: A Mentalizing Model. J Pers Disord. 2008;22:4-21.
8. Kellogg SH, Young JE. Schema therapy for borderline personality disorder. J Clin Psychol. 2006;62:445-458.
9. Stein DJ, Moeller FG. The man who turned bad. CNS Spectr 2005;10:88-90.
10. Johnson PA, Hurley RA, Benkelfat C, Herpertz SC, Taber KH. Understanding emotion regulation in borderline personality disorder: contributions of neuroimaging. J Neuropsychiatry Clin Neurosci. 2003;15:397-402. (Pubitemid 37444581)
11. Stein DJ, Horn N, Ramesar R, et al. Bipolar Disorder: Emotional Dysregulation and Neuronal Vulnerability. CNS Spectr. 2009;14:122-126.
12. Stein DJ, Fan J, Fossella J, Russell VA. Inattention and hyperactivity-impulsivity: psychobiological and evolutionary underpinnings of ADHD. CNS Spectr. 2007;12:190-196. (Pubitemid 46555887)
13. Rosenthal MZ, Gratz KL, Kosson DS, et al. Borderline personality disorder and emotional responding: A review of the research literature. Clin Psychol Rev. 2008;28:75-91.
14. Oldham JM. Borderline Personality Disorder Comes of Age. Am J Psychiatry. 2009;166: 509-511
15. Stein DJ. Empathy: At the heart of the mind. CNS Spectr. 2005;10:780-783.
16. Stein DJ. How we see others: the psychobiology of schemas and transference. CNS Spectr. 2009;14:10-13.
17. Stein DJ. What is the self? A psychobiological perspective. CNS Spectr. 2007;12:333-336
18. Berlin HA, Rolls ET, Iversen SD. Borderline personality disorder, impulsivity, and the orbitofrontal cortex. Am J Psychiatry. 2005;162:2360-2373. (Pubitemid 41740216)
19. New AS, Goodman M, Triebwasser J, Siever LJ. Recent advances in the biological study of personality disorders. Psychiatr Clin North Am. 2008;31:441-461. (Pubitemid 351970124)
20. Schmahl C, Bremner JD. Neuroimaging in borderline personality disorder. J Psychiatr Res. 2006;40:419-427.
21. Lis E, Greenfield B, Henry M, Guile JM, Dougherty G. Neuroimaging and genetics of borderline personality disorder: a review. J Psychiatr Neurosci. 2007;32:162-173. (Pubitemid 46903857)
22. Goyer PF, Andreason PJ, Semple WE, et al. Positron-emission tomography and personality disorders. Neuropsychopharmacology. 1994;10:21-28.
23. De La Fuente JM, Goldman S, Stanus E, et al. Brain glucose metabolism in borderline personality disorder. J Psychiatr Res. 1997;31:531-541. (Pubitemid 27443114)
24. Lyoo IK, Han MH, Cho DY. A brain MRI study in subjects with borderline personality disorder. J Affect Disord. 1998;50:235-243.
25. Schmahl CG, Elzinga BM, Vermetten E, Sanislow C, McGlashan TH, Bremner JD. Neural correlates of memories of abandonment in women with and without borderline personality disorder. Biol Psychiatry. 2003;54:142-151. (Pubitemid 36859774)
26. Tebartz van Elst L, Hesslinger B, Thiel T, et al. Frontolimbic brain abnormalities in patients with borderline personality disorder: A volumetric magnetic resonance imaging study. Biol Psychiatry. 2003;54:163-171. (Pubitemid 36859776)
27. Vollm, B, Richardson, P, Stirling, et al. Neurobiological substrates of antisocial and borderline personality disorder: preliminary results of a functional fMRI study. Crim Behav Ment Health. 2004;14:39-54. (Pubitemid 38102037)
28. Minzenberg MJ, Fan J, New AS, Tang CY, Siever LJ. Fronto-limbic dysfunction in response to facial emotion in borderline personality disorder: An event-related fMRI study. Psychiatry Res. 2007;155:231-243. (Pubitemid 47042366)
29. Silbersweig D, Clarkin JF, Goldstein M, et al. Failure of Frontolimbic Inhibitory Function in the Context of Negative Emotion in Borderline Personality Disorder. Am J Psychiatry. 2007;164:1832-1841. (Pubitemid 351739236)
30. Wingenfeld K, Rullkoetter N, Mensebach C, et al. Neural correlates of the individual emotional Stroop in borderline personality disorder. Psychoneuroendocrinology. 2009;34:571-586.
31. Hazlett EA, New AS, Newmark R, et al. Reduced anterior and posterior cingulate gray matter in borderline personality disorder. Biol Psychiatry. 2005;58:614-623. (Pubitemid 41565576)
32. Donegan NH, Sanislow CA, Blumberg HP, et al. Amygdala hyperreactivity in borderline personality disorder: Implications for emotional dysregulation. Biol Psychiatry. 2003;54:1284-1293, (Pubitemid 37464873)
33. Herpertz SC, Dietrich TM, Wenning B, et al. Evidence of abnormal amygdala functioning in borderline personality disorder: a functional MRI study. Biol Psychiatry. 2001;15:292-298. (Pubitemid 32778446)
34. Schmahl CG, Vermetten E, Elzinga BM, Douglas Bremner J. Magnetic resonance imaging of hippocampal and amygdala volume in women with childhood abuse and borderline personality disorder. Psychiatry Res. 2003;122:193-198. (Pubitemid 36412194)
35. Driessen M, Herrmann J, Stahl K, et al. Magnetic resonance imaging volumes of the hippocampus and the amygdala in women with borderline personality disorder and early traumatization. Arch Gen Psychiatry. 2000;57:1115-1122.
36. New AS, Hazlett EA, Buchsbaum MS, et al. Amygdala-prefrontal disconnection in borderline personality disorder. Neuropsychopharmacology. 2009;32:1629-1640.
37. Schmahl C, Bohus M, Esposito F, et al. Neural correlates of antinociception in borderline personality disorder. Arch Gen Psychiatry. 2006;63:659-667. (Pubitemid 43848297)
38. Schnell K, Dietrich T, Schnitker R, Daumann J, Herpertz SC. Processing of autobiographical memory retrieval cues in borderline personality disorder. J Affect Disord. 2007;97:253-259. (Pubitemid 44937422)
39. King-Casas B, Sharp C, Lomax-Bream L, Lohrenz T, Fonagy P, Montague PR. The rupture and repair of cooperation in borderline personality disorder. Science. 2008;321:806-810.
40. Brambilla P, Soloff PH, Sala M, Nicoletti MA, Keshavan MS, Soares JC. Anatomical MRI study of borderline personality disorder patients. Psychiatry Res. 2004;131:125-133. (Pubitemid 39094646)
41. Zetzsche T, Preuss UW, Frodl T, et al. Hippocampal volume reduction and history of aggressive behaviour in patients with borderline personality disorder. Psychiatry Res. 2007;154:157-170. (Pubitemid 46275439)
42. Irle E, Lange C, Sachsse U. Reduced size and abnormal asymmetry of parietal cortex in women with borderline personality disorder. Biol Psychiatry. 2005;57:173-182. (Pubitemid 40094718)
43. Rusch N, Weber M, Il'yasovc KA, et al. Inferior frontal white matter microstructure and patterns of psychopathology in women with borderline personality disorder and comorbid attention-deficit hyperactivity disorder. Neuroimage. 2007;35:738-747. (Pubitemid 46400549)
44. Grant JE, Correia S, Brennan-Krohn T, Malloy PF, Laidlaw DH, Schulz SC. Frontal White Matter Integrity in Borderline Personality Disorder With Self-Injurious Behavior. J Neuropsychiatry Clin Neurosci. 2007;19:383-390. (Pubitemid 350156095)
45. van Elst LT, Ludaescher P, Thiel T, et al. Evidence of disturbed amygdala energy metabolism in patients with borderline personality disorder. Neurosci Lett. 2007;417:36-41. (Pubitemid 46517846)
46. Hollander E, Stein DJ, DeCaria CM, et al. Serotonergic sensitivity in borderline personality disorder: preliminary findings. Am J Psychiatry. 1994;151:277-280. (Pubitemid 24053115)
47. Stein DJ, Hollander E, DeCaria CM, et al. m-Chlorophenylpiperazine challenge in borderline personality disorder: relationship of neuroendocrine response, behavioral response, and clinical measures. Biol Psychiatry. 1996;40:508-513. (Pubitemid 26319617)
48. Leyton M, Okazawa H, Diksic M, et al. Brain regional α-[11C] methyl-Ltryptophan trapping in impulsive subjects with borderline personality disorder. Am J Psychiatry. 2001;158:775-782. (Pubitemid 32429847)
49. Soloff PH, Meltzer CC, Greer PJ, Constantine D, Kelly TM. A fenfluramine-activated FDG-PET study of borderline personality disorder. Biol Psychiatry. 2000;47:540-547. (Pubitemid 30129082)
50. Siever LJ, Buchsbaum M, New A, et al. d,l-fenfluramine response in impulsive personality disorder assessed with [18F]deoxyglucose positron emission tomography. Neuropsychopharmacology. 1999;20:413-423. (Pubitemid 29123869)
51. Frankle WG, Lombaro I, New AS, et al. Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN5652. Am J Psychiatry. 2005;162:915-923.
52. Soloff PH, Price JC, Meltzer CC, Fabio A, Frank GK, Kaye WH. 5HT(2A) receptor binding is increased in borderline personality disorder. Biol Psychiatry. 2007;62:580-587. (Pubitemid 47314369)
53. New AS, Hazlett EA, Buchsbaum MS, et al. Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Arch Gen Psychiatry. 2002;59:621-629.
54. Herman BH. A possible role of proopiomelanocortin peptides in self-injurious behavior. Prog Neuropsychopharmacol Biol Psychiatry. 1990;14:S109-S139.
55. Stein DJ, van Honk J, Ipser J, et al. Opioids: from physical pain to the pain of social isolation. CNS Spectr. 2007;12:669-670, 672-674. (Pubitemid 47571966)
56. Stein DJ, Vythilingum B. Love and attachment: the psychobiology of social bonding. CNS Spectr. 2009;14:239-242.
57. Bailey JM, Shriver A. Does childhood sexual abuse cause borderline personality disorder? J Sex Marital Ther. 1999;25:45-47. (Pubitemid 29037438)
58. Stein DJ. Emotional regulation: Implications for the psychobiology of psychotherapy. CNS Spectr. 2008;13:195-198.
59. Siever LJ, Torgersen S, Gunderson JG, Livesley WJ, Kendler KS. The borderline diagnosis III: Identifying endophenotypes for genetic studies. Biol Psychiatry. 2002;51:964-968. (Pubitemid 34607712)
60. Gillath O, Shaver PR, Baek JM, Chun DS. Genetic correlates of adult attachment style. Pers Soc Psychol Bull. 2008;34:1396-1405.
61. Gunderson JG, Lyons-Ruth K. BPD's Interpersonal Hypersensitivity Phenotype: A Gene-Environment-Developmental Model. J Pers Disord. 2008;22:22-41.
62. Jacob CP, Müller J, Schmidt M, et al. Cluster B personality disorders are associated with allelic variation of monoamine oxidase A activity. Neuropsychopharmacology. 2005;30:1711-1718. (Pubitemid 43086028)
63. Huang YY, Cate SP, Battistuzzi C, Oquendo MA, Brent D, Mann JJ. An association between a functional polymorphism in the monoamine oxidase a gene promoter, impulsive traits and early abuse experiences. Neuropsychopharmacology. 2004;29:1498-1505. (Pubitemid 38982242)
64. Ni X, Chan K, Bulgin N, et al. Association between serotonin transporter gene and borderline personality disorder. J Psychiatr Res. 2006;40:448-453. (Pubitemid 43816590)
65. Meyer-Lindenberg A, Buckholtz JW, Kolachana B, et al. Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc Natl Acad Sci U S A. 2006;103:6269-6274.
66. Zetzsche T, Preuss UW, Bondy B, et al. 5-HT1A receptor gene C 21019 G polymorphism and amygdala volume in borderline personality disorder. Genes Brain Behav. 2008;7:306-313.
67. Buss DM. Evolutionary personality psychology. Annu Rev Psychol. 1991;45:459-491.
68. Chisholm J. The evolutionary ecology of attachment organization. Hum Nat. 1996;7:1-37.
69. Molina JD, López-Muñoz F, Alamo C, et al. Borderline personality disorder: A review and reformulation from evolutionary theory. Med Hypotheses. 2009. (epub ahead of print)
70. Ruocco AM. Reevaluating the Distinction Between Axis I and Axis II Disorders: The Case of Borderline Personality Disorder. J Clin Psychol. 2005;61:1509-1523. (Pubitemid 43082475)
71. Maunder RG, Hunter JJ. Assessing patterns of adult attachment in medical patients. Gen Hosp Psychiatry. 2009;31:123-130.
72. Choi-Kain LW, Gunderson JG. Mentalization: Ontogeny, Assessment, and Application in the Treatment of Borderline Personality Disorder. Am J Psychiatry. 2008;165:1127-1135.
73. Giesen-Bloo J, van Dyck R, Spinhoven P, et al. Outpatient psychotherapy for borderline personality disorder: Randomized trial of schema-focused therapy vs transference-focused psychotherapy. Arch Gen Psychiatry. 2006;63:649-658. (Pubitemid 43848296)
74. van Asselt ADI, Dirksen CD, Arntz A, et al. Out-patient psychotherapy for borderline personality disorder: cost-effectiveness of schema-focused therapy v. transference-focused psychotherapy. Br J Psychiatry. 2008;192:450-457. (Pubitemid 351809899)
75. Linehan MM. Cognitive-Behavioral Treatment of Borderline Personality Disorder. New York, NY: Guilford Press; 1993.
76. Blum N, St.John D, Pfohl B, et al. Systems Training for Emotional Predictability and Problem Solving (STEPPS) for Outpatients With Borderline Personality Disorder: A Randomized Controlled Trial and 1-Year Follow-Up. Am J Psychiatry. 2008;165:468-478. (Pubitemid 351694290)
77. Zanarini M C. Update on pharmacotherapy of borderline personality disorder. Curr Psychiatry Rep. 2004;6:66-70. (Pubitemid 38899254)
78. Hollander E, Allen A, Lopez RP, et al. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. J Clin Psychiatry. 2001;62:199-203. (Pubitemid 32270095)
79. Paris J, Zweig-Frank H. A 27-year follow-up of patients with borderline personality disorder. Compr Psychiatry. 2001;42:482-487. (Pubitemid 33095793)
80. New AS, Buchsbaum MS, Hazlett EA, et al. Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. Psychopharmacology (Berl). 2004;176:451-458.
81. Schnell K, Herpertz SC. Effects of dialectic-behavioral-therapy on the neural correlates of affective hyperarousal in borderline personality disorder. J Psychiatr Res. 2007;41:837-847. (Pubitemid 46693898)
82. MacKinnon DF, Pies R. Affective instability as rapid cycling: theoretical and clinical implications for borderline personality and bipolar spectrum disorders. Bipolar Disord. 2006;8:1-14. (Pubitemid 43356016)
83. Sripada CS, Silk KR. The Role of Functional Neuroimaging in Exploring the Overlap Between Borderline Personality Disorder and Bipolar Disorder. Curr Psychiatry Rep. 2007;9:40-45.
84. van der Kolk B, Pelcovitz D, Roth S, Mandel F, McFarlane A, Herman JL. Dissociation, somatization, and affect dysregulation: The complexity of adaptation to trauma. Am J Psychiatry. 1996;153(Suppl 7):83-93. (Pubitemid 26230447)
85. Schmahl CG, Vermetten E, Elzinga BM, et al. A positron emission tomography study of memories of childhood abuse in borderline personality disorder. Biol Psychiatry. 2004;55:759-765. (Pubitemid 38376189)
86. Driessen M, Beblo T, Mertens M, et al. Posttraumatic stress disorder and fMRI activation patterns of traumatic memory in patients with borderline personality disorder. Biol Psychiatry. 2004;55:603-611. (Pubitemid 38315034)